Addiction
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) |
HHS-NIH11 |
06/02/2022 |
11/14/2022 | |
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
HHS-NIH11 |
05/09/2022 |
03/21/2025 | |
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
HHS-NIH11 |
05/09/2022 |
03/21/2025 | |
|
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed) |
HHS-NIH11 |
03/14/2022 |
08/15/2022 | |
|
Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional) |
HHS-NIH11 |
03/14/2022 |
08/15/2022 | |
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
HHS-NIH11 |
03/14/2022 |
11/15/2024 | |
|
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) |
HHS-NIH11 |
01/20/2022 |
05/22/2023 | |
|
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) |
HHS-NIH11 |
01/20/2022 |
05/22/2023 | |
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
HHS-NIH11 |
09/02/2021 |
09/08/2024 | |
|
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
HHS-NIH11 |
03/26/2021 |
03/08/2024 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
HHS-NIH11 |
11/16/2020 |
11/15/2023 |
|
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) |
HHS-NIH11 |
10/27/2020 |
11/15/2023 |
|
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
HHS-NIH11 |
09/29/2020 |
10/31/2023 |
|
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional ) |
HHS-NIH11 |
08/28/2020 |
08/11/2023 |
|
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) |
HHS-NIH11 |
08/28/2020 |
08/11/2023 |
|
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
HHS-NIH11 |
07/17/2020 |
11/17/2022 |
|
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
NIH |
10/18/2019 |
11/07/2022 |